Actavis executive resigns

G. Frederick Wilkinson, President of Actavis (ACT) Global R&D, resigns to accept the CEO job at Impax Laboratories (IPXL). Mr. Wilkinson will depart on April 25.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs